
John Mark Pharmaceuticals Limited
About John Mark Pharmaceuticals Limited
Data last updated:
John Mark Pharmaceuticals Limited is a public limited company based in Pune, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 December 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2022PLC216794.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Dinesh Pralhadsing Rajput and Ravindra Utreshwar Ghumbre.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Falt No D Wing D/701 Sr No 105/1 Runal Gatway Ha Veli Pune Dehu Road, Maharashtra, India – 412101.
Company details
Contact details
John Mark Pharmaceuticals Limited's registered office is in Pune, Maharashtra.
- Registered AddressFalt No D Wing D/701 Sr No 105/1 Runal Gatway Ha Veli Pune Dehu Road, Maharashtra, India – 412101
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of John Mark Pharmaceuticals Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of John Mark Pharmaceuticals Limited, buy the company report.
Board of directors of John Mark Pharmaceuticals Limited
John Mark Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Pralhadsing Rajput | Director | 09 Dec 2022 | 3 Years 10 Months | Current |
| Ravindra Utreshwar Ghumbre | Director | 09 Dec 2022 | 3 Years 10 Months | Current |
| Arjunsingh Jyotsingh Chavan Also directs: Sejon Pharma Private Limited | Director | 09 Dec 2022 | 3 Years 10 Months | Current |
| Mayur Pramod Panjabi | Director | 18 Sep 2024 | 2 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving John Mark Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for John Mark Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for John Mark Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
John Mark Pharmaceuticals Limited has 4 board changes on record since 2022: 4 appointments. The latest: Mayur Pramod Panjabi was appointed as Director on 18 Sep 2024.
Frequently asked questions
John Mark Pharmaceuticals is an active public limited company based in Pune, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 09 December 2022 (4+ years old) and is registered under CIN U51909PN2022PLC216794.
John Mark Pharmaceuticals has 4 current directors:
- Dinesh Pralhadsing Rajput - Director
- Ravindra Utreshwar Ghumbre - Director
- Arjunsingh Jyotsingh Chavan - Director
- Mayur Pramod Panjabi - Director
The latest financial statements of John Mark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of John Mark Pharmaceuticals is U51909PN2022PLC216794. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
John Mark Pharmaceuticals was incorporated on 09 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
Mayur Pramod Panjabi was appointed as Director on 18 Sep 2024. Arjunsingh Jyotsingh Chavan was appointed as Director on 09 Dec 2022. Dinesh Pralhadsing Rajput was appointed as Director on 09 Dec 2022. John Mark Pharmaceuticals has 4 board changes on record in total.
The registered office of John Mark Pharmaceuticals is at Falt No D Wing D701 Sr No 1051 Runal Gatway Ha Veli Pune Dehu Road, Maharashtra, India – 412101.
John Mark Pharmaceuticals operates in the trading industry, in the specialty segment.
John Mark Pharmaceuticals can be reached at its registered office: Falt No D Wing D701 Sr No 1051 Runal Gatway Ha Veli Pune Dehu Road, Maharashtra, India – 412101.
John Mark Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.

